Hepatic and splanchnic perfusion and oxygenation after transjugular intrahepatic portosystemic shunt

Revista Espanola de Enfermedades Digestivas

Volumn 92, Issue 4, 2000, Pages 205-210

  Cervera, Manuel ^a   Anon R ^a   Palmero, J ^a   Martinez J ^a   Garces R ^a   Ripolles T ^a   Moreno Osset, E ^a   Alaman G ^a   Anton Ma D ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Hepatic flow; Liver perfusion; Oxygenation index; Portal flow; Portal hypertension; Transjugular intrahepatic portosystemic shunt

Indexed keywords

ARTICLE; FEMALE; HUMAN; LIVER CIRCULATION; MALE; MIDDLE AGED; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; SPLANCHNIC BLOOD FLOW;

FEMALE; HUMANS; HYPERTENSION, PORTAL; LIVER CIRCULATION; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; SPLANCHNIC CIRCULATION;

EID: 0034166594     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. a ed. Barcelona: Medicine; 1984. p. 405-15.
2. Shybayama Y, Nakata K. Localization of increased hepatic vascular resistance in liver cirrhosis. Hepatology 1985;5: 643-8.
3. Nakano M, Worner TM, Lieber CS. Perivenular fibrosis in alcoholic liver injury: ultrastructure and histologic progression. Gastroenterology 1982;83:777-85.
4. Orrego H, Blendis LM, Crossley IR, Medline A, Macdonald A, Ritchie S, et al. Correlation of intrahepatic pressure with collagen in the Disse space and hepatomegaly in humans and in rats. Gastroenterology 1981;80:546-53.
5. a ed. Philadelphia: Saunders; 1990. p. 530-7.
6. Benoit J, Granger DN. Splanchnic hemodynamics in portal hypertension. Sem Liv Dis 1986;6:287-98.
7. Groszmann RJ. Mechanism of portal hypertension: collateral formation and rupture. En: Arroyo V, Bosch J, Rodes J, ed. Treatment in hepatology. Barcelona: Masson; 1995. p. 3-8.
8. Sherwin R, Joshi P, Hendler R, Felig P, Conn HO. Hyperglucagonemia in Laennec's cirrhosis, the role of portal systemic shunting. N Engl J Med 1974;290:239-42.
9. Kravetz D, Bosch J, Arderiu MT, Pizcueta MP, Casamitjana R, Rivera F, et al. Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats. Am J Physiol 1988;254:G322-G8.
10. Mittal MK, Lee FY, Groszmann RJ. Role of nitric oxide in the intrahepatic portal circulation of cirrhotic rats (abstract). Gastroenterology 1993;104:A956.
11. Sieber CC, Groszmann RJ. Nitric oxide mediates hyporeactivity to vasopressor in mesenteric vessels of portal hypertensive rats. Gastroenterology 1992;103:235-9.
12. LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, et al. Creation of transjugular portosystemic shunt with Wallstent endoprosthesis: results in 100 patients. Radiology 1993; 1987:413-20.
13. Ochs A, Rössle M, Haag K, Hauenstein KH, Deibert P, Slegerstetter V, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995;332:1192-7.
14. Noeldge G, Richter GM, Rössle M, Haag K, Katzen BT, Becker GJ. Morphologic and clinical results of the transjugular intrahepatic portosystemic stent-shunt (TIPS). Cardiovas Intervent Radiol 1992;15:342-8.
15. Rypins EB, Milne N, Sarfeh IJ. Analysis of nutrient hepatic blood after 8 mm versus 16 mm portocaval H-graft in a prospective randomized trial. Am J Surg 1995;169:1997-2000.
16. Capusotti L, Vergara V, Polastri R, Marucci MM, Bouzari H, Fava C. A critical appraisal of the small diameter portocaval H-graft. Am J Surg 1995;170:10-4.
17. Riggio O, Merlli M, Pedretti G, Servi R, Meddi P, Lionetti R, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors. Dig Dis Sci 1996;41:578-84.
18. Sanyal AJ, Freedman AM, Shiffman ML, Purdum III PP, Luketic VA, Cheatham AK. Portosystemic encephalopathy after transjugular portosystemic shunt: results of the prospective controlled study. Hepatology 1994;20:46-55.
19. Shroeder TJ, Pesce AJ. Lidocaine as liver fuction test. En: Seminars on liver disease. Philadelphia: Institute for Clinical Science; 1989. p. 79-84.
20. Benowitz NL. Clinical application of the pharmacokinetics of lidocaine. En: Melmon KL, ed. Cardiovascular drug therapy. Philadelphia: De Davis; 1974. p. 77-101.
21. Richter GM, Noeldge G, Palmaz JC, Roessle M, Slegerstetter V, Franke M, et al. Transjugular intrahepatic portocaval stent shunt: preliminary clinical results. Radiology 1990; 174:1027-30.
22. Rössle M, Haag K, Ochs A, Sellinger M, Nöldge G, Perarnau JM, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994;330:165-71.
23. François E, García-Pagan JC, Bru C, Feu F, Gilabert R, Escorsell A, et al. Efectos de la derivación portosistémica percutánea intrahepática sobre la hemodinámica esplácnica y sistémica en pacientes con hipertensión portal. Gastroenterol Hepatol 1997;20:11-4.
24. Encarnacion CE, Palmaz JC, Rivera FJ, Álvarez OA, Chintapalli KN, Lutz JD, et al. Transjugular intrahepatic portosystemic shunt placement for variceal bleeding: predictors of mortality. J Vasc Interv Radiol 1995;6:687-94.
25. Rubin RA, Haskal ZJ, O'Brien CB, Cope C, Brass CA. Transjugular intrahepatic portosystemic shunting: decreased survival for patients with high APACHE II scores. Am J Gastroenterol 1995;90:556-61.
26. Van der Linden PH, Le Moin O, Ghysels M, Ortinez M, Déviere J. Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: Effects on right ventricular function. Hepatology 1996;23:982-7.
27. Azoulay D, Castaing D, Dennison A, Martino W, Eyraud D, Bismuth H. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study. Hepatology 1994;19:129-32.
28. Colombato LA, Spahr L, Martinet J-P, Dufresne M-P, Lafortune M, Fenyves D, et al. Haemodynamic adatptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients. Gut 1996; 39:600-4.
29. Foshager MC, Ferral H, Nazarian GK, Castaneda-Zuniga WR, Letourneau JG. Duplex sonography after transjugular intrahepatic portosystemic shunt (TIPS): normal hemodynamic findings and efficacy in predicting shunt patency and stenosis. Am J Roentgenol 1995;165:1-7.
30. Debatin JF, Zahner B, Meyenberger C, Romanowski B, Schöpke W, Marincek B, et al. Azygos blood flow phase contrast quantitation in volunteers and patients with portal hypertension pre and postintrahepatic shunt placement. Hepatology 1996;24:1109-15.
31. a ed. Philadelphia: WB Saunders; 1990. p. 30-48.
32. Ternberg JL, Butcher HR. Blood flow relation between hepatic artery and portal vein. Science 1965;150:1030-1.
33. Kainuma M, Fujiwara Y, Kimura N, Shitaokoshi A, Nakashima K, Shimada Y. Monitoring hepatic venous hemoglobin oxygen saturation in patients undergoing liver surgery. Anaesthesiology 1991;75:49-52.
34. Kainuma M, Nakashima K, Sakuma I, Kawase M, Komatsu T, et al. Hepatic venous hemoglobin oxygen saturation predicts liver dysfunction after hepatectomy. Anaesthesiology 1992;76:379-86.
35. Dahn MS, Lange MP, Lobdell K, Hans B, Jacobs LA, Mitchell RA. Splanchnic and total body oxygen consumption differences in septic and injured patients. Surgery 1987; 101:69-80.
36. 2 transport and tissue oxygenation in septic shock. En: Reinhart K, Eyrich K, Sprung C, ed. Sepsis: Current perspectives in pathophysiology and therapy. Berlin: Springer-Verlag; 1994. p. 193-213.
37. Bergada J, Pueyo J, Dolz C, Ibáñez J. Efectos hemodinámicos y en la oxigenación sistémica y regional, secundarios al shunt transyugular intrahepático portosistémico. Med Intensiv 1997;21:60-5.